Oct. 31, 2002 — DNAPrint genomics Inc. said it will develop DNA chip-based tests with Nanogen Inc.
The deal calls for Florida-based DNAPrint to make genomics tests using Nanogen’s NanoChip Molecular Biology Workstation. DNAPrint said California-based Nanogen’s platform is well suited for this type of work, which involves the simultaneous reading of large sets of genetic markers or positions per sample, according to a news release.
If performance tests are successful, the two firms will jointly market the new tests for clinical and field application, with Nanogen receiving a royalty on each NanoChip-based test sold. The pact provides DNAPrint a non-exclusive license to perform certain pharmacogenomics, recreational and forensics genomics testing services, the release said.